VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

1,534 hedge funds and large institutions have $107B invested in Vertex Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 119 funds opening new positions, 627 increasing their positions, 573 reducing their positions, and 106 closing their positions.

Holders
1,534
Holders Change
-5
Holders Change %
-0.32%
% of All Funds
22.19%
Holding in Top 10
29
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-12.12%
% of All Funds
0.42%
New
119
Increased
627
Reduced
573
Closed
106
Calls
$881M
Puts
$721M
Net Calls
+$160M
Net Calls Change
+$355M

Top Buyers

1
Edgewood Management
1
Edgewood Management
Connecticut
$719M
2
Jennison Associates
2
Jennison Associates
New York
$2.58B
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$2.23B
4
BlackRock
4
BlackRock
New York
$10.1B
5
Capital Research Global Investors
5
Capital Research Global Investors
California
$4.19B

Top Sellers

1
Norges Bank
1
Norges Bank
Norway
$0
2
MFA
2
Mayflower Financial Advisors
Massachusetts
$689K
3
Goldman Sachs
3
Goldman Sachs
New York
$632M
4
VOYA Investment Management
4
VOYA Investment Management
Georgia
$436M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$822M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital World Investors
1
Capital World Investors
California
$12.5B 26,810,702 +102,736 +0.4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$10.8B 23,159,634 +184,113 +0.8%
BlackRock
3
BlackRock
New York
$10.1B 21,787,546 +475,302 +2%
State Street
4
State Street
Massachusetts
$5.5B 11,816,249 +90,173 +0.8%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$4.89B 10,525,013 -204,415 -2%
Capital Research Global Investors
6
Capital Research Global Investors
California
$4.19B 9,002,205 +462,866 +5%
AllianceBernstein
7
AllianceBernstein
Tennessee
$3.43B 7,372,767 +151,695 +2%
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$3.22B 6,928,587 +328,802 +5%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$2.75B 5,935,888 -389,420 -6%
Jennison Associates
10
Jennison Associates
New York
$2.58B 5,550,386 +851,054 +18%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$2.23B 4,798,870 +704,421 +17%
Amundi
12
Amundi
France
$1.73B 3,759,236 +255,177 +7%
Loomis, Sayles & Company
13
Loomis, Sayles & Company
Massachusetts
$1.43B 3,068,214 -73,957 -2%
Morgan Stanley
14
Morgan Stanley
New York
$1.41B 3,038,437 -220,191 -7%
Massachusetts Financial Services
15
Massachusetts Financial Services
Massachusetts
$1.35B 2,905,705 +159,693 +6%
Bank of America
16
Bank of America
North Carolina
$1.21B 2,608,957 +36,472 +1%
Janus Henderson Group
17
Janus Henderson Group
United Kingdom
$1.17B 2,516,831 +100,114 +4%
UBS AM
18
UBS AM
Illinois
$1.14B 2,441,468 -142,859 -6%
Northern Trust
19
Northern Trust
Illinois
$1.1B 2,365,992 -167,912 -7%
ClearBridge Investments
20
ClearBridge Investments
New York
$917M 1,972,055 -118,649 -6%
Invesco
21
Invesco
Georgia
$904M 1,943,604 +140,862 +8%
Legal & General Group
22
Legal & General Group
United Kingdom
$886M 1,905,312 -67,063 -3%
Ameriprise
23
Ameriprise
Minnesota
$871M 1,871,810 -182,971 -9%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$831M 1,786,728 -50,922 -3%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$822M 1,768,010 -443,664 -20%
1
2 3 4 5